Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ORALEV: Oral Antibiotics in Colon Surgery
NCT02505581Phase 4Completed
- Sponsor
- Vall d'Hebron Research Institute
- Start
- May 2015
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of ciprofloxacin and metronidazole in surgical site infection (SSI) (2 arms), sponsored by Vall d'Hebron Research Institute. Primary endpoint: Wound infection at 30 days. Started May 2015; status: completed.
02
Drugs
ciprofloxacinmetronidazole
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT02505581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02505581.